Amneal Approval Leads Lannett To Job Losses

US Firm Will Consolidate R&D Operation

Document
Another 80 jobs are to go at Lannett to bring down costs • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business